Catheter ablation in patients with persistent atrial fibrillation

Paulus Kirchhof, Hugh Calkins

Research output: Contribution to journalReview articlepeer-review

69 Scopus citations

Abstract

Catheter ablation is increasingly offered to patients who suffer from symptoms due to atrial fibrillation (AF), based on a growing body of evidence illustrating its efficacy compared with antiarrhythmic drug therapy. Approximately one-third of AF ablation procedures are currently performed in patients with persistent or long-standing persistent AF. Here, we review the available information to guide catheter ablation in these more chronic forms of AF. We identify the following principles: Our clinical ability to discriminate paroxysmal and persistent AF is limited. Pulmonary vein isolation is a reasonable and effective first approach for catheter ablation of persistent AF. Other ablation strategies are being developed and need to be properly evaluated in controlled, multicentre trials. Treatment of concomitant conditions promoting recurrent AF by life style interventions and medical therapy should be a routine adjunct to catheter ablation of persistent AF. Early rhythm control therapy has a biological rationale and trials evaluating its value are underway. There is a clear need to generate more evidence for the best approach to ablation of persistent AF beyond pulmonary vein isolation in the form of adequately powered controlled multi-centre trials.

Original languageEnglish (US)
Pages (from-to)20-26
Number of pages7
JournalEuropean heart journal
Volume38
Issue number1
DOIs
StatePublished - Jan 1 2017

Keywords

  • Antiarrhythmic drugs
  • Atrial fibrillation
  • Catheter ablation
  • Clinical practice
  • Complications
  • Exercise
  • Indications
  • Long-standing persistent
  • Outcomes
  • Persistent
  • Rhythm control therapy
  • Sinus rhythm
  • Technique
  • Upstream therapy
  • Weight loss

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Fingerprint

Dive into the research topics of 'Catheter ablation in patients with persistent atrial fibrillation'. Together they form a unique fingerprint.

Cite this